Merz Aesthetics announced the U.S. Food and Drug Administration (FDA) clearance of Ultherapy Prime to improve the appearance of skin laxity on the anterior arms, posterior arms, and abdomen. Ultherapy Prime is the only FDA-cleared device with real-time visualization to treat the face, neck, décolleté, and now body. “This expanded FDA clearance is a testament to our unwavering commitment to advancing innovation that puts patients first,” says Patrick Urban, president of Merz Aesthetics North America. “Building on last year’s successful U.S. Ultherapy Prime launch, we are extending this trusted, proven technology to address a gap in the market and meet customer and patient needs. With these new body indications, providers now have an advanced and trusted device to address the root cause of skin laxity and help achieve personalized firming in the arms and abdomen."
By stimulating the body’s own collagen and elastin production, Ultherapy Prime lifts the brows, the skin under the chin and on the neck, and smooths lines and wrinkles on the décolleté, and now firms and tones the skin on the arms and abdomen in just one session with no downtime and safe for all skin types. It offers personalized, visible natural-looking results, along with younger looking skin, that can last up to a year or more on the face and 6 months or more on the arms and abdomen.